Drug Profile
AB 224050
Alternative Names: ABR 224050Latest Information Update: 27 Jun 2014
Price :
$50
*
At a glance
- Originator Active Biotech
- Developer Lundbeck A/S
- Class Antirheumatics
- Mechanism of Action Dihydroorotate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Rheumatoid arthritis